Anhui Huaheng Biotechnology

Company snapshot

Key words: AMINO ACID, ALANINE, ARBUTIN, MANUFACTURER. Anhui Huaheng Biological Engineering Co., Ltd. was established in April 2005, is a professional engaged in amino acids and other organic acid product development, production and sales of national Torch key high-tech enterprises. The company has successfully undertaken the "863" project of the Ministry of Science and Technology of the Twelfth F

• 2 active pipeline program(s) linked via ClinicalTrials.gov.
• 2 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Anhui Huaheng Biotechnology. Not investment advice.

• What is Anhui Huaheng Biotechnology?

  Anhui Hemay Pharmaceutical is a pharma organization headquartered in CN. Primary therapeutic focus areas include Chronic Obstructive Pulmonary Disease, Tuberculosis. NovaPharmaNews links 2 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public F

• Is Anhui Huaheng Biotechnology publicly traded?

  Anhui Huaheng Biotechnology appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does Anhui Huaheng Biotechnology develop or market?

  We link 6 drug profile(s) where Anhui Huaheng Biotechnology is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/anhui-hemay-pharmaceutical-co-ltd#company-drugs.

• What are the latest developments for Anhui Huaheng Biotechnology?

  In the last 12 months our linked public records show 2 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Anhui Huaheng Biotechnology focus on?

  Anhui Huaheng Biotechnology focuses on Chronic Obstructive Pulmonary Disease, Tuberculosis based on our analysis of their pipeline programs and drug development activities.